Revenue
No reported data
Nautilus Biotechnology, Inc. (NAUT)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Research & development | $41.1M | $50.5M | $47.3M | $37.7M | $29.4M | $12.4M |
| Operating expenses | $66.8M | $81.5M | $76.2M | $63.6M | $50.5M | $15.7M |
| Net income | −$59.0M | −$70.8M | −$63.7M | −$57.9M | −$50.3M | −$15.6M |
| Basic EPSper diluted share | -$0.47 | -$0.56 | -$0.51 | -$0.46 | -$0.60 | -$0.54 |
| Diluted EPSper diluted share | -$0.47 | -$0.56 | -$0.51 | -$0.46 | -$0.60 | -$0.54 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 2, 2026Form 4 | AH Bio Fund II, L.P. +5TenPercentOwner | SellCommon Stock · indirect | 384.0K | $2.35 | $902.5K | 971.9K |
| Jun 2, 2026Form 4 | AH Bio Fund II, L.P. +5TenPercentOwner | SellCommon Stock · indirect | 4.62M | $2.35 | $10.85M | 11.68M |
| Mar 4, 2026Form 4 | Patel Sujal MCEO, President, and Secretary | BuyCommon Stock | 25.0K | $2.61 | $65.3K | 10.37M |
| Nov 6, 2025Form 4 | Suzuki KentaroChief Marketing Officer | BuyCommon Stock | 4.0K | $1.49 | $6.0K | 4.0K |
| Sep 8, 2025Form 4 | Patel Sujal MCEO, President, and Secretary | BuyCommon Stock | 83.5K | $0.68 | $56.8K | 10.34M |